Comparative Pharmacology
Head-to-head clinical analysis: POTASSIUM CHLORIDE 0 22 IN DEXTROSE 5 IN PLASTIC CONTAINER versus POTASSIUM CHLORIDE 10MEQ IN PLASTIC CONTAINER.
Peer-Reviewed Evidence
Head-to-head clinical analysis: POTASSIUM CHLORIDE 0 22 IN DEXTROSE 5 IN PLASTIC CONTAINER versus POTASSIUM CHLORIDE 10MEQ IN PLASTIC CONTAINER.
POTASSIUM CHLORIDE 0.22% IN DEXTROSE 5% IN PLASTIC CONTAINER vs POTASSIUM CHLORIDE 10MEQ IN PLASTIC CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Potassium is the principal intracellular cation and is essential for maintaining cellular membrane potential, nerve impulse transmission, and muscle contraction. Dextrose provides calories and may prevent ketosis.
Potassium chloride dissociates into potassium ions, which are essential for maintaining cellular membrane potential, nerve impulse transmission, cardiac contractility, and acid-base balance. Replacement of potassium corrects hypokalemia.
Intravenous; typical adult dose is 10-20 mEq/hour, not exceeding 40 mEq/hour or 150 mEq/day, with continuous cardiac monitoring and serum potassium monitoring.
20-40 mEq potassium chloride intravenously per dose, infused at a rate not exceeding 10 mEq/hour (or 20 mEq/hour in critical care settings), repeated as needed based on serum potassium levels. Maximum daily dose typically 200 mEq.
None Documented
None Documented
The elimination half-life of potassium is not applicable in the traditional sense because potassium is an endogenous ion under tight homeostatic control. After intravenous infusion of a potassium load, the plasma concentration declines with a distribution phase of about 1-2 hours, followed by a slower elimination phase reflecting cellular uptake and renal excretion, with a terminal half-life of approximately 6-8 hours in patients with normal renal function.
Potassium chloride does not have a classic elimination half-life as it is an endogenous electrolyte. The terminal half-life of exogenous potassium is approximately 2-3 hours in healthy individuals, reflecting rapid cellular uptake and renal clearance. In renal impairment, half-life is prolonged.
Renal: >90% of potassium intake is excreted by the kidneys, primarily via distal tubular secretion; fecal: <10%; minor sweat losses. In this formulation (KCl 0.22% in D5W), the potassium content is 2 mEq per 100 mL (approximately 20 mEq/L).
Renal excretion is the primary route; >90% of potassium is excreted by the kidneys, with a small amount lost in feces (via gastrointestinal secretion) and negligible biliary excretion. Renal elimination is regulated by aldosterone and tubular secretion.
Category C
Category C
Electrolyte Supplement
Electrolyte Supplement